Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Annals of Allergy, Asthma & Immunology

• Publication date

  2004-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1081-1206(10)61393-2PMID 15521370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine

  2005cited by this paper
• Psychometric validation of a patient-reported sensory perception and preference instrument: The Sensory Perceptions Questionnaire

  2004cited by this paper
• Patient preferences for acute pain treatment.

  2004cited by this paper
• Patient preferences for treatment of rheumatoid arthritis

  2004cited by this paper
• An experiment on simplifying conjoint analysis designs for measuring preferences.

  2003cited by this paper
• Two multicenter, randomized, single-blind, single-dose, crossover studies of specific sensory attributes of budesonide aqueous nasal spray and fluticasone propionate nasal spray.

  2003cited by this paper
• Assessment of intranasal corticosteroid use in allergic rhinitis: benefits, costs, and patient preferences.

  2002cited by this paper
• Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.

  2002cited by this paper
• Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seasonal allergic rhinitis.

  2002cited by this paper
• Allergic rhinitis and its impact on asthma.

  2001cited by this paper
• Introduction: patient preference of inhaled nasal corticosteroids.

  2001cited by this paper
• Efficacy, safety, and patient preference of inhaled nasal corticosteroids: a review of pertinent published data.

  2001cited by this paper
• Understanding Patient Preferences for the Treatment of Lupus Nephritis With Adaptive Conjoint Analysis

  2001cited by this paper
• Physician prescribing practices: the role of patient preference in the selection of nasal steroids.

  2001cited by this paper
• Physician prescribing practices: the role of patient preference in the selection of nasal steroids.

  2001cited by this paper
• Patient preferences and satisfaction with prescribed nasal steroids for allergic rhinitis.

  2001cited by this paper
• Introduction: patient preference of inhaled nasal corticosteroids.

  2001cited by this paper
• Consensus statement * on the treatment of allergic rhinitis

  2000cited by this paper
• Intranasal corticosteroids for allergic rhinitis: how do different agents compare?

  1999cited by this paper
• PATIENT PREFERENCE AND SENSORY COMPARISONS OF NASAL SPRAY ALLERGY MEDICATIONS

  1999cited by this paper
• Joint Task Force Algorithm and Annotations for Diagnosis and Management of Rhinitis.

  1998cited by this paper
• A Comparison of Aqueous Suspensions of Budesonide Nasal Spray (128 μg and 256 μg Once Daily) and Fluticasone Propionate Nasal Spray (200 μg Once Daily) in the Treatment of Adult Patients with Seasonal Allergic Rhinitis

  1997cited by this paper
• Measuring health-related quality of life in rhinitis.

  1997cited by this paper
• A cost of illness study of allergic rhinitis in the United States.

  1997cited by this paper
• Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC)

  1997cited by this paper
• A comparison of budesonide and beclomethasone dipropionate sprays in the treatment of seasonal allergic rhinitis.

  1994cited by this paper
• Epidemiology of allergic rhinitis.

  1993cited by this paper
• Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: data from the second National Health and Nutrition Examination Survey, 1976 to 1980 (NHANES II).

  1991cited by this paper
• Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: data from the second National Health and Nutrition Examination Survey, 1976 to 1980 (NHANES II).

  1991cited by this paper
• Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history.

  1991cited by this paper
• Conjoint Analysis in Marketing: New Developments with Implications for Research and Practice

  1990cited by this paper

• Stated Preference Research in Otolaryngology: A Scoping Review

  2025cites this paper
• Predicting Adherence to Topical Medications in Chronic Rhinologic Disease: A Systematic Review

  2024influential citation
• EUFOREA Comment on a Misleading Allergic Rhinitis Report [Response to Letter]

  2023cites this paper
• Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia – An Observational Real-World Clinical Study

  2023cites this paper
• Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL)

  2023cites this paper
• Nasal cast deposition for xylo- and oxymetazoline formulations using two different nasal pumps

  2023cites this paper
• Safety Concerns of Nasal Corticosteroids Usage in Patients With Allergic Rhinitis

  2020cites this paper
• Helping Men with Prostate Cancer Determine Their Preferences for Treatment

  2020cites this paper
• Functionally Crippled Nose

  2020cites this paper
• Intranasal Steroid Use and Satisfaction in Allergic Rhinitis: A Cross-Sectional Study from an Asian Perspective

  2020cites this paper
• Comparative study of the efficacy and safety of intranasal azelastine hydrochloride and fluticasone furoate in the treatment of allergic rhinitis

  2020cites this paper
• The Explosion of OTC Management of Allergic Rhinitis: Costs and Risks

  2019cites this paper
• Assessing multidrug administration preferences among incarcerated Filipino elderly: a choice experiment study

  2019cites this paper
• Intranasal Steroid Therapy for Allergic Rhinitis.

  2019cites this paper
• Evaluation of Intranasal Corticosteroid Sensory Attributes and Patient Preference for Fluticasone Furoate for the Treatment of Allergic Rhinitis.

  2019cites this paper
• Current trends in topical therapies for chronic rhinosinusitis: update and literature review

  2017cites this paper
• How can we improve medical adherence to intranasal corticosteroids in children?

  2017cites this paper
• Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis

  2017cites this paper
• Is the Effect and Safety of Single Daily Dose of Fluticasone Nasal Spray Better than Alternate Day Regimen in Allergic Rhinitis

  2017cites this paper
• Management of allergic rhinitis in the era of effective over-the-counter treatments

  2017cites this paper
• Medical adherence to intranasal corticosteroids in adult patients

  2016cites this paper
• A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis

  2016cites this paper
• Occupational Rhinitis Revisited: Emphasis on the Risk Factors in Saudi Industry

  2016cites this paper
• Motivating Patient Adherence to Allergic Rhinitis Treatments

  2015cites this paper
• Allergen Immunotherapy Adherence in the Real World: How Bad Is It and How Can It Be Improved?

  2015cites this paper
• Recommendations for the pharmacologic management of allergic rhinitis.

  2014cites this paper
• Nasal Deposition of Ciclesonide Nasal Aerosol and Mometasone Aqueous Nasal Spray in Allergic Rhinitis Patients

  2014cites this paper
• Understanding Patient Preferences in Medication Nonadherence: A Review of Stated Preference Data

  2014cites this paper
• Intranasal corticosteroids: the role of patient preference and satisfaction.

  2014influential citation
• New intranasal formulations for the treatment of allergic rhinitis.

  2014cites this paper
• Patient satisfaction with beclomethasone dipropionate nasal aerosol device with integrated dose counter during daily use.

  2013cites this paper
• New Therapeutic Options for Allergic Rhinitis: Back to the Future with Intranasal Corticosteroid Aerosols

  2013cites this paper
• Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis

  2013cites this paper
• Validation of the allergic rhinitis treatment satisfaction and preference scale.

  2013cites this paper
• A patient preference and satisfaction study of ciclesonide nasal aerosol and mometasone furoate aqueous nasal spray in patients with perennial allergic rhinitis.

  2013cites this paper
• Beclomethasone dipropionate nasal aerosol with an integrated dose counter: functionality and performance.

  2013cites this paper
• Intranasal Corticosteroids Topical Characteristics: Side Effects, Formulation, and Volume

  2013cites this paper
• Mise en évidence des effets anti-hypertrophiques de carabine dans le cardiomyocyte et caractérisation de ses voies de signalisation

  2012cites this paper
• Medical costs and adherence in patients receiving aqueous versus pressurized aerosol formulations of intranasal corticosteroids.

  2012cites this paper
• Comparison Of Patient Adherence To Intranasal Corticosteroids By Pressurized Metered-dose Inhaler Versus Aqueous Formulations

  2012cites this paper
• du DIPLOME DE DOCTORAT Santé publique - Spécialité Sciences Economiques Humaines et Sociales

  2012cites this paper
• Treatment of Allergic Rhinitis: Anticholinergics, Glucocorticotherapy, Leukotriene Antagonists, Omalizumab and Specific-Allergen Immunotherapy

  2012cites this paper
• SENSORY STUDY OF A NEW FORMULATION OF AZELASTINE NASAL SPRAY WITH REDUCED BITTERNESS

  2011cites this paper
• Clinical use of oral antihistamines and intranasal corticosteroids in patients with allergic rhinitis.

  2011cites this paper
• Nasal Allergies in the Asian–Pacific Population: Results from the Allergies in Asia–Pacific Survey

  2011cites this paper
• Development of a questionnaire to assess experience and preference of intranasal corticosteroids in patients with allergic rhinitis

  2011cites this paper
• Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated

  2010cites this paper
• Fluticasone furoate nasal spray: Profile of an enhanced-affinity corticosteroid in treatment of seasonal allergic rhinitis

  2010cites this paper
• Intranasal Mometasone Furoate for Treatment of Allergic Rhinitis

  2010cites this paper
• Pediatric allergy medications: review of currently available formulations

  2009cites this paper
• Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence

  2009cites this paper
• Therapeutic management of allergic diseases

  2009cites this paper
• Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians

  2009cites this paper
• Erhebung der sensorischen Wahrnehmung und subjektiven Patienteneinschätzung bei der Verabreichung von Nasenspray – Die Nasen-Spray-Sensorik-Skala

  2009cites this paper
• Efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol once daily for the treatment of seasonal allergic rhinitis.

  2009cites this paper
• Use of Discrete Choice Experiments in health economics: An update of the literature

  2009cites this paper
• Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers.

  2009cites this paper
• Intranasal ciclesonide for allergic rhinitis

  2008cites this paper
• Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.

  2008cites this paper
• Fluticasone furoate nasal spray in the treatment of allergic rhinitis

  2008cites this paper
• Caring for patients with allergic rhinitis

  2007cites this paper
• Once-Daily Administration of Intranasal Corticosteroids for Allergic Rhinitis: A Comparative Review of Efficacy, Safety, Patient Preference, and Cost

  2007cites this paper
• Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance

  2007cites this paper
• Optimization of intranasal corticosteroid formulations for the treatment of allergic rhinitis.

  2007cites this paper
• Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis.

  2007cites this paper
• Patient and physician perspectives on the attributes of nasal allergy medications.

  2007cites this paper
• An evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study*

  2006cites this paper
• What Is the Future of Thiazolidinediones (TZDs) After Market Introduction of Inhaled Insulin?

  2006cites this paper
• Willingness to Pay for Sensory Attributes of Intranasal Corticosteroids Among Patients With Allergic Rhinitis

  2006influential citation
• Evaluation of Product Switching After a State Medicaid Program Began Covering Loratadine OTC 1 Year After Market Availability

  2006cites this paper
• Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis.

  2006cites this paper
• Measuring Value in the Treatment of Symptoms of Allergic Rhinitis With Nasal Steroids

  2006cites this paper
• Allergic Rhinitis in Children: Selecting an Intranasal Corticosteroid

  2005cites this paper
• Patient Related Outcome Measures Dovepress Psychometric Validation of the Experience with Allergic Rhinitis Nasal Spray Questionnaire

  year unknowncites this paper